Balloon angioplasty, with and without stenting, versus medical therapy for hypertensive patients with renal artery stenosis.

@article{Jenks2014BalloonAW,
  title={Balloon angioplasty, with and without stenting, versus medical therapy for hypertensive patients with renal artery stenosis.},
  author={S. Jenks and S. E. Yeoh and B. Conway},
  journal={The Cochrane database of systematic reviews},
  year={2014},
  volume={12},
  pages={
          CD002944
        }
}
BACKGROUND Atherosclerotic renal artery stenosis is the most common cause of secondary hypertension. Balloon angioplasty with stenting is widely used for the treatment of hypertensive patients with renal artery stenosis but the effectiveness of this procedure in treating hypertension, improving renal function and preventing adverse cardiovascular and renal events remains uncertain. This is an update, to include the results of recent, important large trials, of a review first published in 2003… Expand
How should we define appropriate patients for percutaneous transluminal renal angioplasty treatment?
TLDR
This review compares international guidelines related to PTRA, reevaluates the effects of PTRA treatment on blood pressure and renal and cardiac function, discusses strategies for the management of RVH patients, and identifies factors that may predict which patients are most likely to benefit from PTRA. Expand
Resistant Hypertension and Atherosclerotic Renal Artery Stenosis: Effects of Angioplasty on Ambulatory Blood Pressure. A Retrospective Uncontrolled Single-Center Study.
TLDR
Angioplasty in patients with atherosclerotic renal artery stenosis and with true resistant hypertension significantly decreased dABP, reducing the need for antihypertensive treatment with no change in estimated glomerular filtration rate. Expand
Effects of percutaneous angioplasty on kidney function and blood pressure in patients with atherosclerotic renal artery stenosis
TLDR
PTA/S might improve BP control and kidney function in patients with ARAS presenting with high-risk clinical features and should be based on individual assessment of the clinical significance of renal artery stenosis. Expand
Endovascular Treatment Versus Medical Therapy for Hypertensive Patients with Renal Artery Stenosis: An Updated Systematic Review.
TLDR
A systematic review replicates the same research methods and meta-analysis while expanding it to include papers between 2014 and 2018, which showed no heterogeneity between trials and no significant improvement shown by balloon angioplasty, with or without stenting, versus medical therapy. Expand
Selection of patients for angioplasty for treatment of atherosclerotic renovascular disease: predicting responsive patients.
TLDR
The identification of ARAS patients who will potentially respond well to angioplasty is discussed, and lower age, more severe stenosis, preserved renal perfusion, and absence of diabetes or generalized atherosclerosis have been reported as the predictors for the improvement of hypertension after angiopLasty. Expand
Renal Artery Stenosis in Patients with Resistant Hypertension: Stent It or Not?
TLDR
To identify those patients who would definitely respond to renal artery stenting, properly designed randomized clinical trials are definitely needed. Expand
Comparative Effectiveness of Management Strategies for Renal Artery Stenosis
TLDR
It is timely to reevaluate the comparative benefits and harms of strategies for management of patients with ARAS and to identify factors that may predict which patients are most likely to benefit from each intervention. Expand
Renal artery stenosis of a solitary kidney with successful salvage of unusual complication of renal artery angioplasty
TLDR
To the authors' knowledge, this is the first time to report PTRA complication of a broken guide catheter tip in the aorta and the renal artery with successful salvage of the renal arteries in the literature. Expand
Percutaneous transluminal renal angioplasty of global kidney ischemia improves renal function and blood pressure
TLDR
PTRA in patients with GKI led to improved blood pressure and renal function, and a large, well-designed, randomized clinical trial targeting this population is still needed. Expand
Outcomes of Percutaneous Renal Artery Revascularization versus Medical Therapy in Atherosclerotic Renal Artery Stenosis : A Meta-Analysis
Background: Atherosclerotic renovascular disease is an increasingly prevalent condition associated with other macrovascular diseases. To date, randomized controlled trials have demonstrated limitedExpand
...
1
2
3
4
...

References

SHOWING 1-10 OF 34 REFERENCES
Balloon angioplasty versus medical therapy for hypertensive patients with renal artery obstruction.
TLDR
Available data are insufficient to conclude that balloon angioplasty is superior to medical therapy in lowering blood pressure of patients with renal artery stenosis in whom blood pressure can be controlled with medical therapy. Expand
Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis
TLDR
In hypertensive patients with atheromatous renal artery stenosis, percutaneous renal angioplasty results in a modest improvement in systolic BP compared with medical therapy alone, confined to patients with bilateral disease. Expand
The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group.
TLDR
In the treatment of patients with hypertension and renal-artery stenosis, angioplasty has little advantage over antihypertensive-drug therapy. Expand
Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial.
TLDR
A randomized clinical trial contrasting optimum medical therapy alone to stenting with optimum medical Therapy on a composite cardiovascular and renal end point and determining the incremental value of stent revascularization, in addition to optimal medical therapy, for the treatment of atherosclerotic renal artery stenosis. Expand
The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale, design and inclusion data.
TLDR
The aim of the DRASTIC study is to assess the prevalence of renal artery stenosis in patients with well-defined forms of drug-resistant hypertension, and to determine the predictive value of clinical characteristics and diagnostic tests in these pre-selected patients. Expand
Stent Placement in Patients With Atherosclerotic Renal Artery Stenosis and Impaired Renal Function: A Randomized Trial
TLDR
Stent placement with medical treatment had no clear effect on progression of impaired renal function but led to a small number of significant procedure-related complications, which favor a conservative approach to patients with ARAS. Expand
Revascularization versus medical therapy for renal-artery stenosis.
TLDR
It is found that substantial risks are found but no evidence of a worthwhile clinical benefit from revascularization in patients with atherosclerotic renovascular disease. Expand
The benefit of STent placement and blood pressure and lipid-lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR-study: rationale and study design.
TLDR
The STAR-study aims to compare the effects of renal artery stent placement together with medication vs. medication alone on renal function in ARAS patients, with primary outcome a reduction in Cr clearance > 20% compared to baseline. Expand
The Medical and Endovascular Treatment of Atherosclerotic Renal Artery Stenosis (METRAS) study: rationale and study design
TLDR
This study designed a randomized clinical trial based on an optimized patient selection strategy and hard experimental endpoints to determine whether PTRAS is superior or equivalent to optimal medical treatment for preserving glomerular filtration rate (GFR) in the ischemic kidney as assessed by 99mTcDTPA sequential renal scintiscan. Expand
Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far
TLDR
A pooled analysis of all patients in the ASTRAL trial shows that serum creatinine increased in the first 6 months then remained relatively steady, whereas blood pressure has decreased from baseline, which indicates that ASTRAL will provide the most reliable and timely evidence on the role of revascularization in ARVD. Expand
...
1
2
3
4
...